Mizuho Raises Harmony Biosciences (NASDAQ:HRMY) Price Target to $44.00
Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target lifted by equities research analysts at Mizuho from $42.00 to $44.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s target price points to a potential upside of 27.91% from the stock’s […]
Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target lifted by equities research analysts at Mizuho from $42.00 to $44.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s target price points to a potential upside of 27.91% from the stock’s […]
